Loading, Please Wait...
DUBLIN, IRELAND --(Marketwired - March 23, 2016) - Research and Markets has announced the addition of the "Immunotherapeutic Global Market - Forecast To 2021" report to their offering.
The immunotherapeutics global market is expected to grow at mid-range CAGR to reach $138.9 billion by 2021.
Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy.
The report identifies several factors which are driving the growth of the market. They are the:
However, the high cost of the drug development process with a threat of failure in the end stage and reimbursement issues are hampering the growth of the market. The threat to the immunotherapeutics market is reimbursement issue.
The APAC regions suggest an array of opportunities for growth and are likely to be getting into the eyes of new investors in the immunotherapeutics market. Growth in the Asian market is attributed to rising incidence of target diseases, growing geriatric population and better healthcare initiatives by governments and various private organizations.
1 Executive Summary
3 Market Analysis
4 Market, By Type
5 Market, By Application
6 Regional Market Analysis
7 Company Developments
8 Major Player Profiles
For more information visit http://www.researchandmarkets.com/research/w97gbd/immunotherapeutic
Sector: Immune Disorders
Research and Markets
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716